Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.

Asra Minerals, Errawarra Resources and Trek Metals have all raised funds recently to support drill programs that could power ...

Graphite is vital for EV anodes, but has slipped under the radar when it comes to attempts to break China's critical minerals ...

The ASX has had a wobbly start to trading, dipping marginally in the first hour as US GDP falls 0.3pc, undermined by a spike ...

Good morning! Here’s everything you need to know, and some things you don't, before the ASX flings open its doors and begins ...

A powerful showing by Australian tech stocks has pulled the ASX out of the red to post a 0.24pc gain despite weakness in ...

New drill results from Legacy Minerals’ Drake project in NSW are turning heads, revealing untapped potential for major ...

Control Bionics, LTR Pharma and Lumos Diagnostics are among ASX health companies reporting strong quarterly results this week ...

Kidney drug developer Dimerix has struck a partnering deal with a Nasdaq listed company that could deliver more than $1 billion in payments.

Decidr AI Industries and Adisyn are among ASX technology companies reporting March quarterly results this week.

ASX continues winning streak, Tesla quietly preps for life after Elon, and Andromeda hits ultra-pure alumina breakthrough.

Everest Metals (ASX:EMC) has landed support from CSIRO to advance testing of its Direct Rubidium Extraction process at Mt Edon.